HSF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.193245585147E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.88430004511542E-09 |
Normal-vs-Stage2 |
6.36480000000272E-05 |
Normal-vs-Stage3 |
2.12559969625659E-10 |
Normal-vs-Stage4 |
1.32909999672748E-08 |
Stage1-vs-Stage2 |
6.026000E-01 |
Stage1-vs-Stage3 |
7.782400E-03 |
Stage1-vs-Stage4 |
1.621990E-01 |
Stage2-vs-Stage3 |
4.309400E-01 |
Stage2-vs-Stage4 |
7.020600E-01 |
Stage3-vs-Stage4 |
5.601200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.42210004777854E-09 |
Normal-vs-AfricanAmerican |
3.240200E-04 |
Normal-vs-Asian |
3.985800E-01 |
Caucasian-vs-AfricanAmerican |
3.695200E-01 |
Caucasian-vs-Asian |
9.715900E-02 |
AfricanAmerican-vs-Asian |
3.441800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.99922325758462E-12 |
Normal-vs-Female |
6.61139998303639E-09 |
Male-vs-Female |
3.245600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.235640E-03 |
Normal-vs-Age(41-60Yrs) |
2.70730005080821E-09 |
Normal-vs-Age(61-80Yrs) |
8.84319995009264E-09 |
Normal-vs-Age(81-100Yrs) |
1.01870000002169E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.076800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.354000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.246000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.103000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.208600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.151000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.330830E-01 |
Normal-vs-Grade 2 |
4.45449999997294E-07 |
Normal-vs-Grade 3 |
6.53770038105961E-10 |
Normal-vs-Grade 4 |
1.23779986260786E-10 |
Grade 1-vs-Grade 2 |
4.036400E-01 |
Grade 1-vs-Grade 3 |
4.535600E-02 |
Grade 1-vs-Grade 4 |
1.121960E-02 |
Grade 2-vs-Grade 3 |
7.777200E-03 |
Grade 2-vs-Grade 4 |
1.138760E-03 |
Grade 3-vs-Grade 4 |
2.485800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.41830000258636E-08 |
Normal-vs-ccB subtype |
3.20130000286412E-09 |
ccA subtype-vs-ccB subtype |
1.296580E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.63769994524444E-09 |
Normal-vs-N1 |
5.51610000000258E-05 |
N0-vs-N1 |
7.188400E-02 |
|
|